Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recent progress in ovarian cancer.

× No keyword cloud information.

23 in total

1. Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary.

Authors: Seiji Mabuchi; Chiaki Kawase; Deborah A Altomare; Kenichirou Morishige; Masami Hayashi; Kenjiro Sawada; Kimihiko Ito; Yoshito Terai; Yukihiro Nishio; Andres J Klein-Szanto; Robert A Burger; Masahide Ohmichi; Joseph R Testa; Tadashi Kimura
Journal: Mol Cancer Ther Date: 2010-07-27 Impact factor: 6.261

2. Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance.

Authors: Elizabeth J Renaud; David T MacLaughlin; Esther Oliva; Bo R Rueda; Patricia K Donahoe
Journal: Proc Natl Acad Sci U S A Date: 2004-12-23 Impact factor: 11.205

3. Ultrastructure of clear cell carcinoma of the ovary. Case report and review of the literature.

Authors: C Y Genton
Journal: Virchows Arch A Pathol Anat Histol Date: 1979-12

Review 4. Ovarian tumors. A review.

Authors: R E Scully
Journal: Am J Pathol Date: 1977-06 Impact factor: 4.307

5. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.

Authors: Pradeep S Tanwar; Gayatry Mohapatra; Sarah Chiang; David A Engler; Lihua Zhang; Tomoko Kaneko-Tarui; Yasuyo Ohguchi; Michael J Birrer; Jose M Teixeira
Journal: Carcinogenesis Date: 2013-10-29 Impact factor: 4.944

10. The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling.

Authors: Pradeep S Tanwar; Arno E Commandeur; LiHua Zhang; Makoto M Taketo; Jose M Teixeira
Journal: Carcinogenesis Date: 2012-09-07 Impact factor: 4.944

Recent progress in ovarian cancer.

1. Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary.

2. Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance.

3. Ultrastructure of clear cell carcinoma of the ovary. Case report and review of the literature.

Review 4. Ovarian tumors. A review.

5. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.

Review 6. Ovarian clear cell adenocarcinoma: a continuing enigma.

7. Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.

8. Carcinoid tumors of the ovary.

9. On the histogenesis and morphology of ovarian carcinomas.

10. The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling.